drugset / Trial / NCT00002206

A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs

NCT00002206

Phase 1 Completed 45 enrolled Gilead Sciences
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give adefovir dipivoxil once a day for 4 weeks to HIV-infected patients who never have been treated with anti-HIV medicine. This study also examines how the body processes adefovir dipivoxil.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir dipivoxil Small molecule 60 mg